R. Goodwin

发表

Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws.

J. Hirvonen, M. Huestis, K. Scheidweiler, 2013, Clinical chemistry.

Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.

J. Hirvonen, M. Huestis, Allan J. Barnes, 2011, Clinical chemistry.

Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.

W. M. Bosker, J. Hirvonen, J. Ramaekers, 2016, Drug testing and analysis.

Psychomotor Function in Chronic Daily Cannabis Smokers during Sustained Abstinence

W. M. Bosker, J. Hirvonen, R. Innis, 2013, PloS one.

Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol and 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol in Human Plasma After Controlled Oral Administration of Cannabinoids

Richard A. Gustafson, M. Huestis, E. Moolchan, 2006 .

Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?

M. Huestis, Allan J. Barnes, G. Milman, 2013, Drug and alcohol dependence.

Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence.

M. Huestis, C. N. Chiang, Shou-Hua Li, 2008, Journal of analytical toxicology.

Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.

D. Kelly, M. Huestis, D. Gorelick, 2009, Clinical chemistry.

Methadone and Metabolites in Hair of Methadone-Assisted Pregnant Women and Their Infants

H. Jones, M. Huestis, Rolley E. Johnson, 2012, Therapeutic drug monitoring.

3,4-Methylenedioxymethamphetamine (MDMA) and metabolites disposition in blood and plasma following controlled oral administration

Nathalie A. Desrosiers, M. Huestis, D. Gorelick, 2013, Analytical and Bioanalytical Chemistry.

Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration.

M. Huestis, S. Wright, W. Darwin, 2011, Clinical chemistry.

Flavonoids from Brickellia glutinosa.

T. Mabry, K. A. Rosler, R. Goodwin, 1984, Journal of natural products.

Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers

Garth E. Terry, N. Volkow, J. Hirvonen, 2012, Molecular Psychiatry.

Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration.

H. Jones, M. Huestis, D. Jasinski, 2007, Clinical chemistry.

Tolerance to effects of high-dose oral δ9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers.

D. Kelly, M. Huestis, D. Gorelick, 2013, Journal of analytical toxicology.

Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC.

D. Kelly, M. Huestis, D. Gorelick, 2012, Drug and alcohol dependence.

Physiological and Subjective Responses to Controlled Oral 3,4-Methylenedioxymethamphetamine Administration

Marilyn A Huestis, Elliot A Stein, E. Stein, 2008, Journal of clinical psychopharmacology.

Disposition of MDMA and metabolites in human sweat following controlled MDMA administration.

M. Huestis, D. Gorelick, B. D. de Martinis, 2009, Clinical chemistry.

Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine After Controlled Oral Administration to Young Adults

E. Stein, M. Huestis, D. Gorelick, 2008, Therapeutic drug monitoring.

Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.

Marilyn A Huestis, M. Huestis, D. Gorelick, 2009, Journal of analytical toxicology.

Signal-Averaged Electrocardiogram in Physically Healthy, Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Users

M. Huestis, D. Gorelick, Erin A Kolbrich, 2008, The American journal of drug and alcohol abuse.

Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.

D. Kelly, M. Huestis, D. Gorelick, 2011, Clinical chemistry.

Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment.

J. Hirvonen, M. Huestis, D. Gorelick, 2013, The American journal on addictions.

Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers.

D. Kelly, M. Huestis, D. Gorelick, 2013, The American journal on addictions.

Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration.

D. Kelly, M. Huestis, D. Gorelick, 2010, Clinical chemistry.

Oral fluid and plasma 3,4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration

Nathalie A. Desrosiers, M. Huestis, D. Gorelick, 2013, Analytical and Bioanalytical Chemistry.

Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration

M. Huestis, D. Gorelick, Allan J. Barnes, 2011, Analytical and bioanalytical chemistry.

Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration.

M. Huestis, M. Meyer, D. Gorelick, 2011, Clinical chemistry.

Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humans.

M. Huestis, M. Meyer, D. Gorelick, 2012, Biochemical pharmacology.

Human MDMA (Ecstasy) and Phase I and Phase II Metabolite Urinary Excretion Kinetics Following Controlled MDMA Administration

M. Huestis, M. Meyer, D. Gorelick, 2011 .

MDMA and Metabolite Disposition in Expectorated Oral Fluid After Controlled Oral MDMA Administration

M. Huestis, D. Gorelick, K. Scheidweiler, 2011, Therapeutic drug monitoring.

Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration

M. Huestis, F. Liu, S. Wright, 2011, Clinical pharmacology and therapeutics.

Antagonist-Elicited Cannabis Withdrawal in Humans

D. Kelly, M. Huestis, D. Gorelick, 2011, Journal of clinical psychopharmacology.

Methadone and Metabolites in Hair of Methadone-Assisted Pregnant Women and Their Infants

H. Jones, M. Huestis, Rolley E. Johnson, 2012, Therapeutic drug monitoring.